Intravascular large B-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 38: | Line 38: | ||
==Treatment== | ==Treatment== | ||
[[Intravascular large B-cell lymphoma medical therapy|Medical Therapy | [[Intravascular large B-cell lymphoma medical therapy|Medical Therapy]] | [[Intravascular large B-cell lymphoma primary prevention|Primary Prevention]] | [[Intravascular large B-cell lymphoma secondary prevention|Secondary Prevention]] | [[Intravascular large B-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Intravascular large B-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 16:56, 12 September 2012
Intravascular large B-cell lymphoma | ||
ICD-10 | C85.1 | |
---|---|---|
ICD-O: | 9680/0, 9699/3, 9699/3 | |
MeSH | C04.557.386.480.150 |
Intravascular large B-cell lymphoma Microchapters |
Differentiating Intravascular large B-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Intravascular large B-cell lymphoma On the Web |
American Roentgen Ray Society Images of Intravascular large B-cell lymphoma |
Directions to Hospitals Treating Intravascular large B-cell lymphoma |
Risk calculators and risk factors for Intravascular large B-cell lymphoma |
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Intravascular large B-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
See also
References
External links